Dominance status is associated with a variation in cannabinoid receptor 1 expression and amphetamine reward

Copyright © 2022 Elsevier Inc. All rights reserved..

The rewarding effects of psychostimulants appear to be distinct between dominant and subordinate individuals. In turn, the endocannabinoid system is an important modulator of drug reward in the nucleus accumbens and medial prefrontal cortex, however the connection with social dominance is yet to be established. Male rats were classified as dominant or subordinate on the basis of their spontaneous agonistic interactions and drug reward was assessed by means of conditioned place preference with amphetamine (AMPH). In addition, the expression of CB1R, CB2R, FAAH1, and DAGLa was quantified from accumbal and cortical tissue samples. Our findings demonstrate that dominant rats required a lesser dose of AMPH to acquire a preference for the drug-associated compartment, thereby suggesting a higher sensitivity to the rewarding effects of AMPH. Furthermore, dominants exhibited a lower expression of CB1R in the medial prefrontal cortex and nucleus accumbens. This study illustrates how CBR1 expression could differentiate the behavioral phenotypes associated to social dominance.

Medienart:

E-Artikel

Erscheinungsjahr:

2022

Erschienen:

2022

Enthalten in:

Zur Gesamtaufnahme - volume:221

Enthalten in:

Pharmacology, biochemistry, and behavior - 221(2022) vom: 01. Nov., Seite 173483

Sprache:

Englisch

Beteiligte Personen:

Migliaro, Martin [VerfasserIn]
Sánchez-Zavaleta, Rodolfo [VerfasserIn]
Soto-Tinoco, Eva [VerfasserIn]
Ruiz-Contreras, Alejandra E [VerfasserIn]
Méndez-Díaz, Mónica [VerfasserIn]
Herrera-Solís, Andrea [VerfasserIn]
Pérez de la Mora, Miguel [VerfasserIn]
Prospéro-García, Oscar E [VerfasserIn]

Links:

Volltext

Themen:

Amphetamine
CB1R
CK833KGX7E
Central Nervous System Stimulants
Dominance status
Drug reward
Endocannabinoid system
Journal Article
Psychostimulant
Receptor, Cannabinoid, CB1
Research Support, Non-U.S. Gov't
Social brain

Anmerkungen:

Date Completed 12.12.2022

Date Revised 13.12.2022

published: Print-Electronic

Citation Status MEDLINE

doi:

10.1016/j.pbb.2022.173483

funding:

Förderinstitution / Projekttitel:

PPN (Katalog-ID):

NLM347849571